| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $295,230 ) |
| | 2024 | 2024 | ADEPTRIX CORP | 71 CHURCH ST | DORCHESTER | MA | 02122-3027 | SUFFOLK | USA | R43CA291535 | Immunoassay for Measuring Mutation Activated Kinases Across Multiple Cell Signaling Pathways | 000 | 1 | NIH | 6/14/2024 | $295,230 |
|
| Issue Date FY: 2023 ( Subtotal = $1,870,508 ) |
| | 2023 | 2023 | ADEPTRIX CORP | 71 CHURCH ST | DORCHESTER | MA | 02122-3027 | SUFFOLK | USA | R44AG080889 | Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU | 000 | 2 | NIH | 5/18/2023 | $1,433,652 |
| | 2023 | 2023 | ADEPTRIX CORP | 71 CHURCH ST | DORCHESTER | MA | 02122-3027 | SUFFOLK | USA | R44AG080889 | Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU | 001 | 2 | NIH | 7/10/2023 | $0 |
| | 2023 | 2023 | ADEPTRIX CORP | 71 CHURCH ST | DORCHESTER | MA | 02122-3027 | SUFFOLK | USA | R44CA272029 | HistoneScan?: a multiplex immunoassay for histone epigenetic profiling | 000 | 2 | NIH | 7/31/2023 | $436,856 |
|
| Issue Date FY: 2022 ( Subtotal = $1,873,061 ) |
| | 2022 | 2022 | ADEPTRIX CORP. | 71 CHURCH ST STE 6 | BOSTON | MA | 02122-3027 | SUFFOLK | USA | R44CA272029 | HistoneScan?: a multiplex immunoassay for histone epigenetic profiling | 000 | 1 | NIH | 6/28/2022 | $833,042 |
| | 2022 | 2022 | ADEPTRIX CORP. | 71 CHURCH ST STE 6 | BOSTON | MA | 02122-3027 | SUFFOLK | USA | R44AG080889 | Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU | 000 | 1 | NIH | 9/20/2022 | $1,040,019 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2017 | ADEPTRIX CORP. | 71 CHURCH ST STE 6 | BOSTON | MA | 02122-3027 | SUFFOLK | USA | R44GM103348 | PEPTIDE BEAD MICROARRAYS MEASURED BY MASS SPECTROMETRY IMAGING | 000 | 4 | NIH | 6/6/2019 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $740,168 ) |
| | 2017 | 2017 | ADEPTRIX CORP. | 71 CHURCH ST STE 6 | BOSTON | MA | 02122-3027 | SUFFOLK | USA | R44GM103348 | PEPTIDE BEAD MICROARRAYS MEASURED BY MASS SPECTROMETRY IMAGING | 000 | 4 | NIH | 1/20/2017 | $740,168 |
|
| Issue Date FY: 2016 ( Subtotal = $720,069 ) |
| | 2016 | 2016 | ADEPTRIX CORP | 71 CHURCH STREET | BOSTON | MA | 02122 | SUFFOLK | USA | R44GM103348 | PEPTIDE BEAD MICROARRAYS MEASURED BY MASS SPECTROMETRY IMAGING | 000 | 3 | NIH | 3/3/2016 | $720,069 |
|
| Issue Date FY: 2013 ( Subtotal = $349,034 ) |
| | 2013 | 2013 | ADEPTRIX CORP | 71 CHURCH STREET | BOSTON | MA | 02122 | SUFFOLK | USA | R43GM103348 | PEPTIDE BEAD MICROARRAYS MEASURED BY MASS SPECTROMETRY IMAGING | 000 | 2 | NIH | 9/20/2013 | $349,034 |
|
| Issue Date FY: 2012 ( Subtotal = $349,034 ) |
| | 2012 | 2012 | ADEPTRIX CORP | 71 CHURCH STREET | BOSTON | MA | 02122 | SUFFOLK | USA | R43GM103348 | PEPTIDE BEAD MICROARRAYS MEASURED BY MASS SPECTROMETRY IMAGING | 000 | 1 | NIH | 9/17/2012 | $349,034 |
|
|
